Our collaborator, Associate Professor Matt Dun talks about the new PNOC study in an article for the Hunter Medical Research Institute (HMRI).
The design of the study was informed by the work he and his team have conducted at the University of Newcastle and HMRI.
The HMRI team has undertaken laboratory research with paxalisib for several years and has generated a powerful body of data combining paxalisib with other investigational drugs, which will guide combination use in the study.
Read the article here.
